AbbVie's Acquisitions Report Card Shows Investors Have a Reason to Worry About the Allergan Buyout
Here are AbbVie's grades on its previous acquisition deals. And they look ugly overall.
Editors' Picks
How to Invest in the Best Texas Stocks
You'll want to pick your own Texas-based stocks, and following this simple strategy will give you a portfolio you can be proud of.
Why These Coal Giants Are Teaming Up
After working through bankruptcy court, Arch Coal and Peabody Energy are joining forces in this coal region. Here's why.
7 Things You Didn't Know About NIO
This company is charging forward in its attempt to reimagine the Chinese auto landscape.
Recent articles
Don't Count on Medicare to Cover These 4 Things
The government's health insurance program for the elderly has a lot of gaps in its coverage that you'll have to fill -- one way or another.
3 Top Augmented-Reality Stocks to Buy Right Now
Augmented reality is expected to grow 65% annually for the next five years. Here's how you can claim some of that growth.
Kimberly-Clark Earnings: What to Watch
Investors are hoping the company can close the gap with industry leader P&G this quarter.
3 Stocks to Buy Ahead of the Next Market Crash
These stocks should be safer than most when the next major market downturn comes.
3 Money Moves to Make Today If You Plan to Retire Within 20 Years
By checking on your savings now, you can make sure you're prepared to retire in 20 years.
Do You Really Need a Will?
You may think you don't have enough assets to require a will -- but you may be wrong about that.
Stories Could Save Core Facebook Engagement
Stories usage increased 9% sequentially last quarter.
Better Marijuana Stock: HEXO vs. Scotts Miracle-Gro
Which stock wins in a head-to-head matchup between a top U.S. supplier to the cannabis industry and an up-and-coming Canadian cannabis producer?
2 Penny Stock Marijuana Plays That Could Make You Rich
Aleafia Health and MedMen Enterprises are two penny pot stocks worth keeping tabs on.
Amarin: Is a Buyout Really Off the Table?
The market grossly overreacted to Amarin's sizable capital raise last week. Here's why.
Is More Pain in Store for Mattel Shareholders in the Q2 Report?
After a harrowing few years, can the toymaker achieve its much vaunted turnaround?
How to Invest in the Best Texas Stocks
You'll want to pick your own Texas-based stocks, and following this simple strategy will give you a portfolio you can be proud of.
Why These Coal Giants Are Teaming Up
After working through bankruptcy court, Arch Coal and Peabody Energy are joining forces in this coal region. Here's why.
7 Things You Didn't Know About NIO
This company is charging forward in its attempt to reimagine the Chinese auto landscape.
Retirement Savings Falling Short? Try Moving to These States
If you haven't saved as much as you'd hoped, relocating can help make the most of every penny.
AbbVie's Acquisitions Report Card Shows Investors Have a Reason to Worry About the Allergan Buyout
Here are AbbVie's grades on its previous acquisition deals. And they look ugly overall.
You Won't Believe How Complex Our Tax System Is -- Here's How to Make Sense of It
Guess which is longer -- the Harry Potter series or the U.S. tax code?
How Much Will Social Security Pay Me?
Find out how your retirement benefits are calculated.
Better Buy: Disney vs. Netflix
Two of the leading entertainment providers are moving in different directions, but that doesn't mean the stocks will continue to be passing ships.
Is Zoom Video Communications a Buy at All-Time Highs?
The stock is white-hot since its debut, and the future looks bright.